Literature DB >> 25840425

Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Michel J Grothe1, Helmut Heinsen2, Edson Amaro3, Lea T Grinberg4,5, Stefan J Teipel1,6.   

Abstract

Degeneration of basal forebrain (BF) cholinergic nuclei is associated with cognitive decline, and this effect is believed to be mediated by neuronal dysfunction in the denervated cortical areas. MRI-based measurements of BF atrophy are increasingly being used as in vivo surrogate markers for cholinergic degeneration, but the functional implications of reductions in BF volume are not well understood. We used high-resolution MRI, fluorodeoxyglucose-positron emission tomography (PET), and neuropsychological test data of 132 subjects with mild cognitive impairment (MCI) and 177 cognitively normal controls to determine associations between BF atrophy, cortical hypometabolism, and cognitive deficits. BF atrophy in MCI correlated with both impaired memory function and attentional control deficits, whereas hippocampus volume was more specifically associated with memory deficits. BF atrophy was also associated with widespread cortical hypometabolism, and path analytic models indicated that hypometabolism in domain-specific cortical networks mediated the association between BF volume and cognitive dysfunction. The presence of cortical amyloid pathology, as assessed using AV45-PET, did not significantly interact with the observed associations. These data underline the potential of multimodal imaging markers to study structure-function-cognition relationships in the living human brain and provide important in vivo evidence for an involvement of the human BF in cortical activity and cognitive function.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AV45-PET; Alzheimer's disease; FDG-PET; MRI; cholinergic degeneration; nucleus basalis Meynert; substantia innominata

Mesh:

Substances:

Year:  2015        PMID: 25840425      PMCID: PMC4869802          DOI: 10.1093/cercor/bhv062

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  115 in total

1.  Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region.

Authors:  Kathrin Muth; Ralf Schönmeyer; Silke Matura; Corinna Haenschel; Johannes Schröder; Johannes Pantel
Journal:  Biol Psychiatry       Date:  2009-04-17       Impact factor: 13.382

2.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

3.  Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.

Authors:  Kai Kendziorra; Henrike Wolf; Philipp Mael Meyer; Henryk Barthel; Swen Hesse; Georg Alexander Becker; Julia Luthardt; Andreas Schildan; Marianne Patt; Dietlind Sorger; Anita Seese; Herman-Josef Gertz; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-11       Impact factor: 9.236

4.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

5.  The human basal forebrain integrates the old and the new.

Authors:  Eve De Rosa; John E Desmond; Adam K Anderson; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuron       Date:  2004-03-04       Impact factor: 17.173

6.  White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment.

Authors:  Claudio Babiloni; Michela Pievani; Fabrizio Vecchio; Cristina Geroldi; Fabrizio Eusebi; Claudia Fracassi; Evan Fletcher; Charles De Carli; Marina Boccardi; Paolo Maria Rossini; Giovanni B Frisoni
Journal:  Hum Brain Mapp       Date:  2009-05       Impact factor: 5.038

Review 7.  The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury.

Authors:  David B Arciniegas
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

8.  Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment.

Authors:  A M Fjell; K B Walhovd; I Amlien; A Bjørnerud; I Reinvang; L Gjerstad; T Cappelen; F Willoch; P Due-Tønnessen; R Grambaite; A Skinningsrud; V Stenset; T Fladby
Journal:  AJNR Am J Neuroradiol       Date:  2008-06       Impact factor: 3.825

9.  Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.

Authors:  Pietro Tiraboschi; Larry A Hansen; Michael Alford; Annette Merdes; Eliezer Masliah; Leon J Thal; Jody Corey-Bloom
Journal:  Arch Gen Psychiatry       Date:  2002-10

10.  Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

Authors:  Ahmadul Kadir; Niels Andreasen; Ove Almkvist; Anders Wall; Anton Forsberg; Henry Engler; Göran Hagman; Marie Lärksäter; Bengt Winblad; Henrik Zetterberg; Kaj Blennow; Bengt Långström; Agneta Nordberg
Journal:  Ann Neurol       Date:  2008-05       Impact factor: 10.422

View more
  39 in total

1.  The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles.

Authors:  Hans-Christian J Fritz; Nicola Ray; Martin Dyrba; Christian Sorg; Stefan Teipel; Michel J Grothe
Journal:  Hum Brain Mapp       Date:  2018-10-11       Impact factor: 5.038

Review 2.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

Review 3.  Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.

Authors:  Jessika Royea; Edith Hamel
Journal:  Geroscience       Date:  2020-07-22       Impact factor: 7.713

Review 4.  The menagerie of the basal forebrain: how many (neural) species are there, what do they look like, how do they behave and who talks to whom?

Authors:  Chun Yang; Stephen Thankachan; Robert W McCarley; Ritchie E Brown
Journal:  Curr Opin Neurobiol       Date:  2017-05-21       Impact factor: 6.627

5.  Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?

Authors:  K D Jethwa; P Dhillon; D Meng; D P Auer
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

Review 6.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.

Authors:  Chelsea T Tiernan; Elliott J Mufson; Nicholas M Kanaan; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

8.  Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.

Authors:  Anja Soldan; Corinne Pettigrew; Qing Cai; Mei-Cheng Wang; Abhay R Moghekar; Richard J O'Brien; Ola A Selnes; Marilyn S Albert
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

9.  Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.

Authors:  Michel J Grothe; Stefan J Teipel
Journal:  Hum Brain Mapp       Date:  2015-10-06       Impact factor: 5.038

10.  Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia.

Authors:  Nicolaas I Bohnen; Michel J Grothe; Nicola J Ray; Martijn L T M Müller; Stefan J Teipel
Journal:  Curr Geriatr Rep       Date:  2018-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.